1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 South and Central America Multiple Sclerosis Therapeutics Market - By Drug Class
1.3.2 South and Central America Multiple Sclerosis Therapeutics Market - By Route of Administration
1.3.3 South and Central America Multiple Sclerosis Therapeutics Market - By Distribution Channel
1.3.4 South and Central America Multiple Sclerosis Therapeutics Market - By Country

2. Multiple Sclerosis Therapeutics Market - Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. South and Central America Multiple Sclerosis Therapeutics- Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 South and Central America (SCAM) - PEST Analysis
4.3 Expert Opinions

5. Multiple Sclerosis Therapeutics Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Growing Prevalence of Multiple Sclerosis (MS)
5.1.2 Rising Funding for Multiple Sclerosis Research
5.2 Market Restraints
5.2.1 High Cost of Multiple Sclerosis Treatment
5.3 Market Opportunities
5.3.1 Increasing Awareness About Multiple Sclerosis
5.4 Future Trends
5.4.1 Development and Launch of Innovative Products
5.5 Impact analysis

6. Multiple Sclerosis Therapeutics Market - South and Central America Analysis
6.1 South and Central America Multiple Sclerosis Therapeutics Market Revenue Forecast and Analysis

7. Multiple Sclerosis Therapeutics Market Analysis - By Drug Class
7.1 Overview
7.2 Multiple Sclerosis Therapeutics Market Revenue Share, by Drug Class (2019 and 2027)
7.3 Immunosuppressant
7.3.1 Overview
7.3.2 Immunosuppressant: Multiple Sclerosis Therapeutics Market - Revenue and Forecast to 2027 (US$ Million)
7.4 Immunomodulators
7.4.1 Overview
7.4.2 Immunomodulators: Multiple Sclerosis Therapeutics Market - Revenue and Forecast to 2027 (US$ Million)

8. Multiple Sclerosis Therapeutics Market Analysis - By Route of Administration
8.1 Overview
8.2 Multiple Sclerosis Therapeutics Market Revenue Share, by Route of Administration (2019 and 2027)
8.3 Injectable
8.3.1 Overview
8.3.2 Injectable: Multiple Sclerosis Therapeutics Market - Revenue and Forecast to 2027 (US$ Million)
8.4 Oral
8.4.1 Overview
8.4.2 Oral: Multiple Sclerosis Therapeutics Market - Revenue and Forecast to 2027 (US$ Million)

9. Multiple Sclerosis Therapeutics Market Analysis - By Distribution Channel
9.1 Overview
9.2 Multiple Sclerosis Therapeutics Market Share, by Distribution Channel, 2019 and 2027
9.3 Hospital Pharmacies
9.3.1 Overview
9.3.2 Hospital Pharmacies: Multiple Sclerosis Therapeutics Market - Revenue and Forecast to 2027 (US$ Million)
9.4 Retail Pharmacies
9.4.1 Overview
9.4.2 Retail Pharmacies: Multiple Sclerosis Therapeutics Market - Revenue and Forecast to 2027 (US$ Million)
9.5 E-Commerce
9.5.1 Overview
9.5.2 E-Commerce: Multiple Sclerosis Therapeutics Market - Revenue and Forecast to 2027 (US$ Million)

10. Multiple Sclerosis Therapeutics Market Analysis and Forecast To 2027 -South and Central America Analysis
10.1 South and Central America: Multiple Sclerosis Therapeutics Market
10.1.1 Overview
10.1.2 South and Central America: Multiple Sclerosis Therapeutics Market, by Country, 2019 & 2027 (%)
10.1.3 Brazil: Multiple Sclerosis Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
10.1.3.1 Brazil: Multiple Sclerosis Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
10.1.3.2 Brazil: Multiple Sclerosis Therapeutics Market, by Drug Class, 2018-2027 (USD Million)
10.1.3.3 Brazil: Multiple Sclerosis Therapeutics Market, by Route of Administration 2018-2027 (USD Million)
10.1.3.3.1 Brazil: Multiple Sclerosis Therapeutics Market, by Distribution Channel, 2018-2027 (USD Million)
10.1.4 Argentina: Multiple Sclerosis Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
10.1.4.1 Argentina: Multiple Sclerosis Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
10.1.4.2 Argentina: Multiple Sclerosis Therapeutics Market, by Drug Class, 2018-2027 (USD Million)
10.1.4.3 Argentina: Multiple Sclerosis Therapeutics Market, by Route of Administration 2018-2027 (USD Million)
10.1.4.4 Argentina: Multiple Sclerosis Therapeutics Market, by Distribution Channel, 2018-2027 (USD Million)
10.1.5 Rest of South and Central America: Multiple Sclerosis Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
10.1.5.1 Rest of South and Central America: Multiple Sclerosis Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
10.1.5.2 Rest of South and Central America: Multiple Sclerosis Therapeutics Market, by Drug Class, 2018-2027 (USD Million)
10.1.5.3 Rest of South and Central America: Multiple Sclerosis Therapeutics Market, by Route of Administration 2018-2027 (USD Million)
10.1.5.4 Rest of South and Central America: Multiple Sclerosis Therapeutics Market, by Distribution Channel, 2018-2027 (USD Million)

11. Impact of COVID-19 Pandemic on South and Central America Multiple Sclerosis Therapeutics Market
11.1 South and Central America: Impact Assessment of COVID-19 Pandemic

12. Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview

13. Company Profiles
13.1 Merck & Co., Inc.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Novartis AG
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Bayer AG
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Sanofi
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Bristol-Myers Squibb Company
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 TEVA PHARMACEUTICAL INDUSTRIES LTD
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 F. HOFFMANN-LA ROCHE LTD.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Biogen
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

14. Appendix
14.1 About the Insight Partners
14.2 Glossary of Terms

Figure 1. Multiple Sclerosis Therapeutics Market Segmentation
Figure 2. Multiple Sclerosis Therapeutics Market Segmentation, By Country
Figure 3. Multiple Sclerosis Therapeutics Market Overview
Figure 4. Immunomodulators Segment by Drug Class Held the Larger Share of Multiple Sclerosis Therapeutics Market
Figure 5. South and Central America Multiple Sclerosis Therapeutics Market - Leading Country Markets (US$ Million)
Figure 6. South and Central America (SCAM) PEST Analysis
Figure 7. Multiple Sclerosis Therapeutics Market Impact Analysis of Driver and Restraints
Figure 8. South and Central America Multiple Sclerosis Therapeutics Market - Revenue Forecast and Analysis - 2019- 2027
Figure 9. Multiple Sclerosis Therapeutics Market Revenue Share, by Drug Class (2019 and 2027)
Figure 10. Immunosuppressant: Multiple Sclerosis Therapeutics Market - Revenue and Forecast to 2027 (US$ Million)
Figure 11. Immunomodulators: Multiple Sclerosis Therapeutics Market - Revenue and Forecast to 2027 (US$ Million)
Figure 12. Multiple Sclerosis Therapeutics Market Revenue Share, by Route of Administration (2019 and 2027)
Figure 13. Injectable: Multiple Sclerosis Therapeutics Market - Revenue and Forecast to 2027 (US$ Million)
Figure 14. Oral: Multiple Sclerosis Therapeutics Market - Revenue and Forecast to 2027 (US$ Million)
Figure 15. Multiple Sclerosis Therapeutics Market Share, by Distribution Channel, 2019 and 2027
Figure 16. Hospital Pharmacies: Multiple Sclerosis Therapeutics Market - Revenue and Forecast to 2027 (US$ Million)
Figure 17. Retail Pharmacies: Multiple Sclerosis Therapeutics Market - Revenue and Forecast to 2027 (US$ Million)
Figure 18. E-Commerce: Multiple Sclerosis Therapeutics Market - Revenue and Forecast to 2027 (US$ Million)
Figure 19. South and Central America: Multiple Sclerosis Therapeutics Market, by Key Country - Revenue (2019) (USD Million)
Figure 20. South and Central America: Multiple Sclerosis Therapeutics Market, by Country, 2019 & 2027 (%)
Figure 21. Brazil: Multiple Sclerosis Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
Figure 22. Argentina: Multiple Sclerosis Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
Figure 23. Rest of South and Central America: Multiple Sclerosis Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
Figure 24. Impact of COVID-19 Pandemic in South and Central America Market

Table 1. Brazil Multiple Sclerosis Therapeutics Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 2. Brazil Multiple Sclerosis Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 3. Brazil Multiple Sclerosis Therapeutics Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 4. Argentina Multiple Sclerosis Therapeutics Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 5. Argentina Multiple Sclerosis Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 6. Argentina Multiple Sclerosis Therapeutics Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 7. Rest of South and Central America Multiple Sclerosis Therapeutics Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 8. Rest of South and Central America Multiple Sclerosis Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 9. Rest of South and Central America Multiple Sclerosis Therapeutics Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 10. Organic Developments Done By Companies
Table 11. Inorganic Developments Done By Companies
Table 12. Glossary of Terms, Multiple sclerosis therapeutics Market

The List of Companies - South and Central America Multiple Sclerosis Therapeutics Market

? Merck & Co., Inc.
? Novartis AG
? Bayer AG
? Sanofi
? Bristol-Myers Squibb Company
? TEVA PHARMACEUTICAL INDUSTRIES LTD
? F. HOFFMANN-LA ROCHE LTD
? Biogen